Search by Drug Name or NDC

    NDC 68001-0361-05 Montelukast 10 mg/1 Details

    Montelukast 10 mg/1

    Montelukast is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by BluePoint Laboratories. The primary component is MONTELUKAST SODIUM.

    Product Information

    NDC 68001-0361
    Product ID 68001-361_d9dbbe03-bcc4-1af7-e053-2a95a90a8053
    Associated GPIs 44505050100330
    GCN Sequence Number 038451
    GCN Sequence Number Description montelukast sodium TABLET 10 MG ORAL
    HIC3 Z4B
    HIC3 Description LEUKOTRIENE RECEPTOR ANTAGONISTS
    GCN 94444
    HICL Sequence Number 016911
    HICL Sequence Number Description MONTELUKAST SODIUM
    Brand/Generic Generic
    Proprietary Name Montelukast
    Proprietary Name Suffix n/a
    Non-Proprietary Name Montelukast
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 10
    Active Ingredient Units mg/1
    Substance Name MONTELUKAST SODIUM
    Labeler Name BluePoint Laboratories
    Pharmaceutical Class Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203366
    Listing Certified Through 2024-12-31

    Package

    NDC 68001-0361-05 (68001036105)

    NDC Package Code 68001-361-05
    Billing NDC 68001036105
    Package 90 TABLET in 1 BOTTLE (68001-361-05)
    Marketing Start Date 2018-06-29
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.06044
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description MONTELUKAST SOD 10 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL 4c411d3e-47b6-481b-b846-419ed4cbb947 Details

    Revised: 3/2022